Type-1-diabetes, also known as insulin-dependent diabetes mellitus, results from the progressive destruction of pancreatic beta cells resulting in insulin deficiency.Studies on the risk of developing Type-1-diabetes suggested that environmental factors, particularly viruses, may be involved in initiating the destruction of beta cells leading to Type-1-diabetes. The aim of current study was to investigate the possible correlation between human cytomegalovirusand Epstein Barr virus with type 1 diabetes mellitus.Methods: A total of 56 patients diagnosed with Type-1-diabetes who attended the Special Center for Endocrine Glands and Diabetes in Al-Nassyrieh city, and another control group of 30 nondiabetic healthy people were selected. These two groups were of age range 3-22 years old and from both sexes. The sera from both groups were collected and divided into two parts. One part for the serological detection of IgM and IgG antibodies against human cytomegalovirusand Epstein Barr virus by the enzyme-linked immune sorbent assay (ELISA) and another part to detect the viral target genes of human cytomegalovirusand Epstein Barr virus genome by the conventional Polymerase Chain Reaction(PCR) technique.Results: The results revealed that only 2(3.60%) of Type-1-diabetes patients were positive for anti-human cytomegalovirus IgM antibodies compared with a negative result of the control group and 53(94.60%) of Type-1-diabetes patients were positive for anti-human cytomegalovirus IgG antibodies compared with a full percentage in the control group (100.00%). Also, ELISA results indicated the presence of anti-Epstein Barr virus IgM antibodies and anti-Epstein Barr virus IgG antibodies in 7(12.50%) and 24(42.90%) of Type-1-diabetes patients, respectively, compared with negative results for both anti-E[stein Barr virus IgM and IgG antibodies of the control group. Regarding PCR technique, the results revealed that (33.93%) of Type-1-diabetes patients had Human Cytomegalovirus DNA and (26.79%) of Type-1-diabetes patients hadEpstein Barr virus DNA compared with none of the controls had Human Cytomegalovirus DNA or EpsteinBarr virus DNA (P<0.001).Conclusion: According to these results, the current study concluded that Human Cytomegalovirus and EpsteinBarr virus infections may have a role in the pathogenesis, development and progression of type 1 diabetes mellitus.
Introduction
Type 1 diabetes (T1D) is one of the most common chronic diseases that occur during childhood and accounts for about 10% of all cases of diabetes. In this disease, the insulin-producing beta-cells located in the pancreas are gradually destroyed until the amount of insulin produced is not sufficient to keep up a normal level of blood glucose [1] . T1D is an autoimmune disease, which reveals the role of immune response effectors in the pathogenic processes and failure of immune tolerance towards β-cell antigen [2] .
The pathogenesis of T1D is complex and results from a combination of genetic and environmental factors. Viruses considered one of the numerous environmental factors, which together with the genetic susceptibility have been associated with the pathogenesis of autoimmune diabetes [3] . The initial observations that suggested the role viruses in the development of T1D is that the onset of T1D sometimes follows acute infections and occurs with greater frequencies at certain times of the year, which often indicated a viral cause. In addition, the most compelling evidence arosefrom the studies that isolated viruses from the pancreas of patients who died as a result of acute T1D [4] . Various viruses have been reported to be associated with human T1D, such as Enteroviruses [5] , Rubella virus, Mumps virus, Rotavirus, Epstein-Barr virus [6] and Cytomegalovirus [7] .
Human Cytomegalovirus (HCMV) belonging to the Betaherpesvirinae subfamily, is the largest member of the human herpesvirus family [8] . HCMV is responsible for a very common infection, which in the immunocompetent individuals, is usually asymptomatic or may appear as a mononucleosis-like syndrome [9] . In the fetus, newborns, and immunocompromised patients, HCMV infection can cause a range of severe clinical effects [10] [11] [12] . Also, it is suggested that HCMV is associated with several human malignancies such as breast cancer [13] . HCMV is one of the important viral factors that are believed to be linked with the occurrence of T1D because of its ability to induce the immunological damage of βcells [14] . Many clinical studies had associated human Cytomegalovirus (HCMV) infection with the development of T1D in people. The Pathogenic mechanisms underlying HCMV-induced T1D are still unclear, but many hypotheses were discussed [15] .
On the other hand, Epstein-Barr Virus (EBV), also known as human herpesvirus 4, is a γlymphotropic herpesvirus and the causative agent of infectious mononucleosis (IM) [16] and it has been considered as a cause of many cancers, where it has been shown that EBV infection strictly related to malignant lymphomas in Iraq [17, 18] . EBV has been associated with the development of auto-immune diseases because this virus possesses a number of immune evasion mechanisms and immune-modulating proteins that make it a good candidate for the initiation and progression of autoimmune diseases [19] . Therefore, it has been suggested that it is related to the development of T1D [20] . However, studies regarding the association between EBV and the triggering of T1D may be very limited [21] . Also, studies that established the relationship between thesetwo viruses, especially EBV, are very limited.So, the aim of this study wasto conduct an investigation about the association between HCMV and EBV with T1D at serological and PCR levels.
Materials and Method

Samples collection
This case-control study was conducted from September to December 2018. A total of 56 T1D patients, who attended The Special Center for Endocrine Glands and Diabetes in Al-Nassyrieh city, south of Iraq, were involvedin the study and included 24 males and 32 females with diagnostic features of T1D and age range of 3-22 years. The other group of the study included30 apparently non-diabetic healthy people representing the control group (the included males and females were within the same age range of patients group).
Five ml of venous blood was drawn fromeach subject (diabetic patients and controls). The blood samples were collected in coagulates gel tubes and left to clot at room temperature and then centrifuged at 3000rpm for 15 minutes to separate the serum. The serum samples were separated in several 1.5ml tubes that were stored frozen at -20˚C until used to avoid thawing and repeated freezing.
Serological and Molecular study
Serological study ELISA was used in the current study to detect the serum level of anti-HCMV IgM and IgG antibodies by using the CMV IgM ELISA Test kit and CMV IgG ELISA Test kit (foresight/USA) and to detect the presence of anti-EBV EBNA-1 IgM and IgG antibodies by using the EBV EBNA-1 IgM and EBNA-1 IgG antibody test kits (Demeditec/Germany).
Molecular study
DNA extraction
The viral genomic DNA was extracted from serum samples of both patients and control groups by using the viral nucleic acid extraction kit from Geneaid/Taiwan, according to manufacturer's instructions. The quality and purity of extracted DNA were checked by using the Nanodrop that readsthe absorbance at (260/280nm). Then the DNA solution was stored at -20˚C to perform the PCR assay.
Polymerase chain reaction (PCR) assay
The conventional PCR technique was used in this study for amplification the UL57 gene and EBNA-1 gene, which were used for identification HCMV genomic DNA and EBV genomic DNA, respectively. The primers that used in the present study were obtained from previous studies: UL57 (Forward primer: 5'-CATCACGCTATTTTCGCGGGC-3' and reverse primer: 5'-CGGTGATCGGTTGCGTTGGTC-3') [22] ; EBNA-1 (Forward primer: 5'-GTCATCATCATCCGGGTCTC-3' and reverse primer: 5' TTCGGGTTGGAACCTCCTTG-3') [23] .
The PCR master mix (Accupower PCR PreMix) was obtained from Bioneer/ Korea and the reaction mix consisted of 10µl of extracting DNA, 2µl of forward and reverse primers and 6µl distilled water. All these components were placed in the PCR tubes that containedall other components needed forPCR reaction. The final volume in the reaction tube was 20μL. The thermocycling conditions for each gene werementioned inTable (1) . Then the PCR products were visualized by UV transilluminator following electrophoresis on 1.5% agarose gel for UL57 gene and 2% agarose gel for EBNA-1 gene [22, 23] . The statistical analysis of this case-control study was performed with the statistical package for social sciences (SPSS) 20.0 and Microsoft Excel 2013. Numerical data with normal distribution were described as mean and standard deviation and independent sample t-test used for comparison between two groups. Categorical data were described as count and percentage. Chi-squared test or Fisher exact test was used to estimate the association between variables. The lower level of accepted statistically significant difference is bellow or equal to 0.05 and the high level of accepted statistically significant difference is below or equal to 0.001.
Results
Serological results
ELISA results revealed that 2(3.60%) of T1D patients were positive for anti-HCMV IgM antibodies and controls showed negative results (0.00%). There was no significant difference between patients group and controls (P= 0.421; Table 2 ). The results explained that the percentage of anti-HCMV IgG antibody in the T1D patients was (94.60%) and in controls was (100.00%)indicatinga non-significant difference between the two groups (P= 0.271; Table 3 ). Regarding EBV, It was found that 7(12.50%) of patients were seropositive for anti-EBNA-1 IgM, whereas all controls shown a negative result for this type of antibody, which was statistically significant (P= 0.043; Table 4 ). On the other hand, the results showed the presence of anti-EBNA-1 IgG in 49(42.90%) of T1D patients compared with (0.00%) in the control group, indicating a highly significant difference (P ˂0.001; Table 5 ). 
Molecular results
The results of PCR detected that 19(33.93%) of T1D patients were positive for HCMV DNA and 
Discussion
Current study may be performed for the first time in Iraq and Thi-Qar Province to explore the correlation between two dangerous members of herpesviruses, Epstein-Barr virus and human cytomegalovirus, with the development and progression of type 1 diabetes mellitus at serological and PCR levels.
ELISA was used in the current study as a primary test for diagnosis,inpatients with T1D,ofinfection with EBV and HCMV. The results showed that (3.60%) of T1D patients were seropositive for anti-HCMV IgM antibody and there was no significant difference (P=0.421) between T1D patients and controls. This result agreed with results explained by [24] and disagreed with a study conducted in Al-Najaf Province that observed a higher prevalence of anti-HCMV IgM antibodies in patients compared with control group [25] . The presence of anti-HCMV IgM antibody in these patients in conjunction with the onset of the disease and presence of hyperglycemia and elevation of HbA1c mightsuggest the role of the asymptomatic HCMV infection with the development of T1D [26] .
Results concerning anti-HCMV IgG antibodies indicated high anti-HCMV IgG response rates in both groups of the study (patients and controls) with no significant difference (P= 0.271) and this result was consistent with the study that also revealed no correlation between the seroprevalence of anti-HCMV IgG antibody and T1D patients (P= 0.38) [14] . On the other hand, there it had been detected that a significant relationship exists between anti-HCMV IgG antibody and T1D [27] .
The PCR assay was used to confirm the serological results of HCMV. The results revealed that (33.93%) of T1D patients were positive for HCMV DNA compared with none of the controls had the HCMV DNA and this indicated the presence of a significant difference between patients and their controls (P<0.001). Therefore, the findings of this study based on the molecular diagnosis mighthave indicated the potential role of HCMV as a risk factor in T1D development.
HCMV may cause β-cells damage and lead to T1D either directly by the virus inducing cytopathic effects and apoptosis of β-cellsor indirectly by production of low levels of cytokines by β-cells. the latter express toll-like receptors (TLR) 2 and 4. Furthermore, TLR2 has been involved in the binding of HCMV to target cells. It has been shown that TLR-2 activation in β-cells activates NF-kB with subsequent production of low levels of pro-inflammatory cytokines such as IL-1β [28] [29] [30] . IL-1β leads to the production of TNF-α in human pancreatic duct cells, which in turn causes β-cellsapoptosis [31] . T cell cross-reaction by molecular mimicry between β-cell auto-antigens such as GAD-65 and HCMV encoded major DNA-binding protein UL57 regarded one of the key mechanism by which HCMV could cause the autoimmune process. GAD65specific T cell cross-reacts with a peptide of the major DNA-binding protein of HCMV. Dendritic cells can also process this HCMV-derived epitope naturally. Therefore, it has been suggested that HCMV may be involved in the loss of T cell tolerance to the GAD65 auto-antigen. As a result, causing the pancreatic autoimmunity and development of T1D [32] .
The published studies related to the detection of anti-EBV antibodies in T1D patients are very limited or may be rare locally and globally. The results of ELISA in the present study showed the presence of a significant difference between T1D patients and controls (P<0,001) in the detection of anti-EBV IgG antibody. This finding might disagree with the results of another study [33] , that didn't present any significant difference between patients and controls for anti-EBV IgG antibody. With respect to the anti-EBV IgM antibody, the results of this study also showed a significant difference between T1D patients and controls (P= 0.043).
While detection of EBV infection by PCR assay, the results indicated that(26.79%) of diabetic patients gave positive results for EBV DNA, whereas all controls showed negative results for this gene and there was a highly significant difference between the T1D patients and controls (P<0.001). This study disagreedwith another study conducted in India, which did not provide any evidence regarding the relationship between EBV infection and diabetes by PCR or serological tests [34] . Therefore, detection of EBV by serology or by PCR in current study mightdemonstrate the validity of the hypothesis that there is a possible relationship between EBV and T1D.
The mechanism by which EBV could contribute to the pathogenesis of T1D remains uncertain. It is feasible to include many of the necessary mechanisms. First, EBV would result in local antiviral immune response that damages pancreatic beta cells when the virus spreads from β-cells to pancreatic tissue [35] . Second, EBV infection increases cytotoxicity and destruction of the immune cells by causing inflammatory cytokines to be released [36] . Third, EBV infection can cause a cross-reactive autoimmune response through molecular mimicry of viral antigens and host proteins. A five amino acids-long sequence (GPPAA) in the Aspartic-57 region of the HLA-DQ8 β chain, which proposed to be crucial in identifying the risk of T1D, is repeated 6 times in the BRF4-encoded EBNA3C protein of the EBV. Therefore, individuals carrying this sequence (GPPAA) in their HLA-DQ molecule present cross-reactivity to this epitope in EBV and may influence T1D pathogenesis [37] .
Conclusion
In conclusion, the findings of this study suggested the possible association between HCMV and EBV infections with T1D and may be recommended to do more research about this relationship.
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